Melanotan 2.

Melanotan-2 (MT-2) is a cyclic heptapeptide analog of alpha-MSH and MC1R/MC4R agonist. With the molecular formula C₅₀H₆₉N₁₅O₉ and a molecular weight of 1024.2 g/mol (CAS: 121062-08-6), it structurally...

$31.00

Lab Verified

Clinical Grade

PMID Cited

Mechanism of Action.

Published preclinical research has characterized the following molecular pathways and receptor interactions for Melanotan 2.

Receptor interaction

Melanocortin 4 Receptor (MC4R)

Published research demonstrates Melanotan-2 (MT-2) modulates targeted signaling cascades within cell tissue models.

Signaling cascade

Melanocortin 1 Receptor (MC1R)

In cellular environments, Melanotan-2 (MT-2) exhibits selective binding and corresponding pathway activation.

Evidence Based

Clinical Literature

View All Studies

Preclinical

Research review on Melanotan 2 molecular characterization.

Preclinical studies have characterized the molecular properties and receptor binding profiles of Melanotan 2 in standardized assay systems.

Preclinical

Melanotan 2 structure-activity relationship analysis.

Structure-activity relationship studies have examined the functional domains and binding characteristics of Melanotan 2 in cell-free and cell-based systems.

RESEARCH USE ONLY: This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. Must be 21+ to purchase.

Continue Exploring